When additional IOP reduction may be needed for a patient on PGA therapy

SIMBRINZA® Suspension should be taken at least five (5) minutes apart from other topical ophthalmic drugs.1

Ann, 77*

*Hypothetical patient

Patient Details

  • Open-angle glaucoma patient with elevated IOP
  • On PGA therapy that has reduced her IOP from 26 mm Hg OU to 18 mm Hg OU for several years
  • Maintains an active lifestyle with an upbeat, independent attitude

Status

  • Recently, Ann's IOP has risen to around 22 mm Hg OU, and optic nerve damage has progressed
  • She is cognizant of the need to work toward a target IOP and a reduction of approximately 5 mm Hg

Treatment Plan

  • Consider adding SIMBRINZA® Suspension to a PGA

When you want to replace a single component with a combination

Joe, 67*

*Hypothetical patient

Patient Details

  • Open-angle glaucoma patient
  • Currently treated with a PGA and brimonidine 0.2%
  • No comorbid conditions

Status

  • Joe was started on a prostaglandin 6 months ago and achieved IOP lowering
  • He was later prescribed brimonidine 0.2% and obtained additional IOP control, but he still needs additional IOP reduction to reach his target IOP
  • He is concerned about adding another bottle to his regimen

Treatment Plan

  • Consider using SIMBRINZA® Suspension to replace Joe's brimonidine 0.2% to maintain his burden of therapy (number of bottles used per day) while offering additional IOP lowering
  • Counsel Joe about lowering his IOP and give him the SIMBRINZA® Suspension QuickTip brochure

Reference: 1. SIMBRINZA® Suspension [prescribing information]. Fort Worth, TX: Alcon Laboratories Inc; 2015.